Associations of breast cancer with IGFs and steroid hormonesa
Variable . | 1st quartileb (Reference) . | 2nd quartile OR (95% CI) . | 3rd quartile OR (95% CI) . | 4th quartile OR (95% CI) . | P for trend . | Median cutoff . |
---|---|---|---|---|---|---|
Premenopausal women | ||||||
IGF-I | 1.00 | 1.41 (0.72–2.77) | 1.48 (0.72–3.06) | 2.66 (1.40–5.05) | 0.003 | 1.78c |
IGF-II | 1.00 | 1.88 (0.86–4.11) | 1.15 (0.41–3.28) | 1.69 (0.61–4.73) | 0.378 | 0.82 |
IGFBP-3 | 1.00 | 1.17 (0.57–2.39) | 2.17 (1.05–4.46) | 4.26 (1.89–9.63) | <0.001 | 2.56c |
Estradiol | 1.00 | 0.61 (0.31–1.18) | 0.62 (0.33–1.15) | 0.68 (0.37–1.26) | 0.265 | 0.83 |
Estrone | 1.00 | 1.02 (0.52–2.03) | 1.44 (0.75–2.79) | 1.46 (0.78–2.76) | 0.149 | 1.44 |
Estrone-S | 1.00 | 1.00 (0.53–1.91) | 0.97 (0.47–1.99) | 1.21 (0.65–2.27) | 0.514 | 1.11 |
Testosterone | 1.00 | 1.38 (0.62–3.06) | 1.17 (0.51–2.66) | 2.92 (1.27–6.70) | 0.009 | 1.46 |
DHEA-S | 1.00 | 0.80 (0.42–1.53) | 0.92 (0.48–1.74) | 1.43 (0.77–2.68) | 0.187 | 0.85 |
SHBG | 1.00 | 0.76 (0.39–1.48) | 0.73 (0.37–1.43) | 0.73 (0.36–1.49) | 0.418 | 0.91 |
Progesterone | 1.00 | 1.38 (0.70–2.72) | 1.25 (0.62–2.55) | 0.82 (0.40–1.70) | 0.450 | |
Postmenopausal women | ||||||
IGF-I | 1.00 | 1.34 (0.61–2.96) | 1.05 (0.44–2.52) | 2.11 (0.92–4.86) | 0.108 | 1.29 |
IGF-II | 1.00 | 0.89 (0.46–1.72) | 1.63 (0.68–3.90) | 2.21 (0.70–6.96) | 0.259 | 1.78 |
IGFBP-3 | 1.00 | 1.17 (0.58–2.39) | 1.43 (0.71–2.89) | 2.86 (1.02–7.99) | 0.059 | 1.55 |
Estrone | 1.00 | 0.81 (0.33–1.98) | 0.82 (0.35–1.93) | 2.67 (1.17–6.07) | 0.007 | 1.79c |
Estrone-S | 1.00 | 0.56 (0.22–1.41) | 1.41 (0.56–3.57) | 0.72 (0.31–1.68) | 1.000 | 1.32 |
Testosterone | 1.00 | 0.58 (0.25–1.35) | 1.04 (0.47–2.33) | 1.87 (0.84–4.20) | 0.034 | 1.89c |
DHEA-S | 1.00 | 1.89 (0.87–4.11) | 1.27 (0.61–2.65) | 2.92 (1.28–6.67) | 0.037 | 1.40 |
SHBG | 1.00 | 1.00 (0.46–2.19) | 0.86 (0.39–1.88) | 0.79 (0.36–1.74) | 0.487 | 0.92 |
Variable . | 1st quartileb (Reference) . | 2nd quartile OR (95% CI) . | 3rd quartile OR (95% CI) . | 4th quartile OR (95% CI) . | P for trend . | Median cutoff . |
---|---|---|---|---|---|---|
Premenopausal women | ||||||
IGF-I | 1.00 | 1.41 (0.72–2.77) | 1.48 (0.72–3.06) | 2.66 (1.40–5.05) | 0.003 | 1.78c |
IGF-II | 1.00 | 1.88 (0.86–4.11) | 1.15 (0.41–3.28) | 1.69 (0.61–4.73) | 0.378 | 0.82 |
IGFBP-3 | 1.00 | 1.17 (0.57–2.39) | 2.17 (1.05–4.46) | 4.26 (1.89–9.63) | <0.001 | 2.56c |
Estradiol | 1.00 | 0.61 (0.31–1.18) | 0.62 (0.33–1.15) | 0.68 (0.37–1.26) | 0.265 | 0.83 |
Estrone | 1.00 | 1.02 (0.52–2.03) | 1.44 (0.75–2.79) | 1.46 (0.78–2.76) | 0.149 | 1.44 |
Estrone-S | 1.00 | 1.00 (0.53–1.91) | 0.97 (0.47–1.99) | 1.21 (0.65–2.27) | 0.514 | 1.11 |
Testosterone | 1.00 | 1.38 (0.62–3.06) | 1.17 (0.51–2.66) | 2.92 (1.27–6.70) | 0.009 | 1.46 |
DHEA-S | 1.00 | 0.80 (0.42–1.53) | 0.92 (0.48–1.74) | 1.43 (0.77–2.68) | 0.187 | 0.85 |
SHBG | 1.00 | 0.76 (0.39–1.48) | 0.73 (0.37–1.43) | 0.73 (0.36–1.49) | 0.418 | 0.91 |
Progesterone | 1.00 | 1.38 (0.70–2.72) | 1.25 (0.62–2.55) | 0.82 (0.40–1.70) | 0.450 | |
Postmenopausal women | ||||||
IGF-I | 1.00 | 1.34 (0.61–2.96) | 1.05 (0.44–2.52) | 2.11 (0.92–4.86) | 0.108 | 1.29 |
IGF-II | 1.00 | 0.89 (0.46–1.72) | 1.63 (0.68–3.90) | 2.21 (0.70–6.96) | 0.259 | 1.78 |
IGFBP-3 | 1.00 | 1.17 (0.58–2.39) | 1.43 (0.71–2.89) | 2.86 (1.02–7.99) | 0.059 | 1.55 |
Estrone | 1.00 | 0.81 (0.33–1.98) | 0.82 (0.35–1.93) | 2.67 (1.17–6.07) | 0.007 | 1.79c |
Estrone-S | 1.00 | 0.56 (0.22–1.41) | 1.41 (0.56–3.57) | 0.72 (0.31–1.68) | 1.000 | 1.32 |
Testosterone | 1.00 | 0.58 (0.25–1.35) | 1.04 (0.47–2.33) | 1.87 (0.84–4.20) | 0.034 | 1.89c |
DHEA-S | 1.00 | 1.89 (0.87–4.11) | 1.27 (0.61–2.65) | 2.92 (1.28–6.67) | 0.037 | 1.40 |
SHBG | 1.00 | 1.00 (0.46–2.19) | 0.86 (0.39–1.88) | 0.79 (0.36–1.74) | 0.487 | 0.92 |